FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine
Status: Currently in Shortage
»Date first posted: 02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric

Expand all

Fresenius Kabi USA, LLC (Reverified 12/13/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17) Backordered. Next release date not available at this time. Check wholesalers for inventory.

Dear Customer Letter

Manufacturing delay
Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17) Backordered. Next release date not available at this time. Check wholesalers for inventory.

Dear Customer Letter

Manufacturing delay
Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17) Backordered. Next release date not available at this time.

Dear Customer Letter

Manufacturing delay
Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17) Backordered. Next release date not available at this time.

Dear Customer Letter

Manufacturing delay

Hospira, Inc. (Revised 12/01/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 0409-0996-01) Next delivery & Estimated recovery TBD Shortage per Manufacturer: Manufacturing Delay. Other
0.5% w/EPI 1:200,000; 50 mL vial (NDC 0409-3177-01) Next delivery: 2Q 2018; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
1% w/EPI 1:100,000; 20 mL vial (NDC 0409-3178-01) Next delivery: Early December 2017; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
1% w/EPI 1:100,000; 30 mL vial (NDC 0409-3178-02) Next delivery: Mid December 2017; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
1% w/EPI 1:100,000; 50 mL vial (NDC 0409-3178-03) Next delivery: Late December 2017; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-01) Next delivery: January 2018; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay. Other
1.5% w/EPI 1:200,000; 30 mL amp (NDC 0409-3181-01) Next delivery: 1Q 2018; Estimated recovery: June 2018 Shortage per Manufacturer: Manufacturing Delay. Other
2% w/EPI 1:100,000; 20 mL vial (NDC 0409-3182-01) Next delivery: 2Q 2018; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
2% w/EPI 1:100,000; 30 mL vial (NDC 0409-3182-02) Next delivery: 2Q 2018; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
2% w/EPI 1:100,000; 50 mL vial (NDC 0409-3182-03) Next delivery: 1Q 2018; Estimated recovery: June 2018 Shortage per Manufacturer: Manufacturing Delay. Other
2% w/EPI 1:200,000; 20 mL vial (NDC 0409-3183-01) Next delivery: 2Q 2018; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay. Other
2% w/EPI 1:50,000; 1.8mL syringe (NDC 0409-7263-01) Estimated delivery and recovery TBD Shortage per Manufacturer: Manufacturing Delay. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English